Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Income (2022 - 2025)

Envoy Medical's Operating Income history spans 4 years, with the latest figure at -$6.4 million for Q4 2025.

  • Quarterly results put Operating Income at -$6.4 million for Q4 2025, down 40.36% from a year ago — trailing twelve months through Dec 2025 was -$22.3 million (down 15.65% YoY), and the annual figure for FY2025 was -$22.3 million, down 15.65%.
  • Operating Income for Q4 2025 was -$6.4 million at Envoy Medical, down from -$5.7 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$901356.0 in Q2 2022 to a low of -$6.7 million in Q4 2023.
  • The 4-year median for Operating Income is -$4.7 million (2024), against an average of -$4.2 million.
  • The sharpest move saw Operating Income plummeted 397.03% in 2023, then soared 32.34% in 2024.
  • Year by year, Operating Income stood at -$2.9 million in 2022, then tumbled by 131.35% to -$6.7 million in 2023, then soared by 32.34% to -$4.5 million in 2024, then crashed by 40.36% to -$6.4 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$6.4 million, -$5.7 million, and -$5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.